Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

ACC raises red flags over telehealth, payment reform and the cardiologist shortage
"We need telehealth the way we had it for COVID," Cathie Biga told Cardiovascular Business at TCT 2025. "We don't want to go back to having it so restricted."
Radiologists remain dominant specialty for key clot-busting procedure, with opportunity for expansion
Cardiologists recorded the biggest overall uptick in claims at roughly 185%, according to research published Thursday in the Journal of the American College of Radiology.
Healthcare AI today: Rusty clinical skills, AI growing up so fast, AI for the malnourished
Clinicians who come to rely on AI for decision support risk the dulling of their skills. The concern is not new. But now comes a pointed call to researchers: Inquire about the particulars of the peril.
Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly
Pfizer was all set to acquire New York City-based Metsera for $4.9 billion, but Novo Nordisk stepped in with an unexpected counteroffer of $6.5 billion. Both companies hope to add Metsera's drugs to their GLP-1 portfolios.
Hospital giant Intermountain Health to acquire Las Vegas radiology practice
The Salt Lake City-headquartered nonprofit is buying Steinberg Diagnostic Medical Imaging for an undisclosed sum, with the integration taking place sometime after Jan. 1.

Physicians personally linked to cancer 18% more likely to recommend additional screening

Physicians who have a personal connection to cancer are nearly 18 percent more likely to act against established guidelines and recommend cancer screening for low-risk patients, specifically ovarian cancer screening in women, according to the Journal of Women’s Health.

Primary care group raises $350M

One Medical Group, a primary care group with offices in San Francisco, New York, Seattle and other cities, has closed a $350 million investment from the Carlyle Group, a private equity group based in Washington, D.C., TechCrunch reported.

Medicare could save nearly $1B by buying generics over brand names

Medicare could be saving a lot of cash by switching to generic constituents for some drugs—maybe as much as a billion dollars.
A recent study estimated spending in 2016 on 29 brand-name combination products would have been $925 million more than spending for generic counterparts.

Should patients undergo screening mammography after autologous breast reconstruction?

Screening mammography is a reasonable surveillance tool for breast cancer patients treated with mastectomy and breast reconstruction with autologous myocutaneous flaps (AMFs), according to new research published in Radiology. Mammography provides little additional value, however, if the patient had reconstruction after a prophylactic mastectomy.

Morgan Stanley: 20% of hospitals at risk of closure

Nearly 20 percent of U.S. hospitals are at risk of potential closure or are in weak shape, according to a recent report from Morgan Stanley.

$85M approved for healthcare studies

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors, an independent nonprofit organization authorized by Congress, has approved $85 million for 16 new studies to improve care and outcomes for several conditions.

Irish radiologist misreads CT, misses tumor of patient who died 2 weeks later

A locum radiologist working at Mayo University Hospital in Castlebar, Ireland, reportedly failed to read an elderly woman’s CT correctly upon her admission in September 2017, missing a rectal tumor that killed her two weeks later, the Mayo News reported this week.

Study: Cost-effectiveness of cardiovascular drugs varies widely

The publicly available prices of 30 frequently prescribed cardiovascular drugs don’t necessarily correlate to clinical value, according to a new study. Some drugs were both cheaper and more effective than alternatives, while others were more expensive and associated with poorer outcomes.

Management

ACC raises red flags over telehealth, payment reform and the cardiologist shortage

Radiologists remain dominant specialty for key clot-busting procedure, with opportunity for expansion

Healthcare AI today: Rusty clinical skills, AI growing up so fast, AI for the malnourished

Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly

Hospital giant Intermountain Health to acquire Las Vegas radiology practice